Advanced Cell Technology Announces Alternative Approach for Derivation of Embryonic Stem Cell Lines
Approach Maintains Developmental Potential of Embryo Worcester, MA – Advanced Cell Technology, Inc (OTC Bulletin Board: ACTC.OB) reported today the…
Approach Maintains Developmental Potential of Embryo Worcester, MA – Advanced Cell Technology, Inc (OTC Bulletin Board: ACTC.OB) reported today the…
MARLBOROUGH, Mass. — Jan. 5, 2012 – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative…
WORCESTER, MA — (BUSINESS WIRE) Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC) announced today that it has completed key animal studies…
Study suggests hESCs could serve as a safe source of cells to treat diseases of the eye WORCESTER, Mass.– (BUSINESS…
Third Stargardt’s Patient in EU Trial Treated with RPE Cells Derived from Human Embryonic Stem Cells at Moorfields Eye Hospital…
Ideal candidate for early clinical trials involving iPS cells MARLBOROUGH, MA – January 11, 2011. Advanced Cell Technology, Inc. (OTCBB:ACTC)…
MARLBOROUGH, Mass. — Jan. 25, 2012 – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative…
BLOOD donations may one day be a thing of the past thanks to the creation of the first functional red blood…
UCLA’s Investigator IND Application for Embryonic Stem Cell-Based Clinical Trial to Evaluate Safety and Tolerability in Patients with Severe Myopia,…
Phase 1/2 Clinical Trials of RPE Cells for the Treatment of Dry Age-Related Macular Degeneration and Stargardt’s Macular Degeneration Show Positive Long…